In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ortho-Clinical Diagnostics Inc.

www.orthoclinical.com

Latest From Ortho-Clinical Diagnostics Inc.

MTI 100: Major M&A Bookends Year Of Mainly Steady Growth For Leading Medtech Groups

In Medtech Insight's latest rankings of top 100 revenue-earners in the medical device and diagnostics sector, it was steady as she goes for most of the multinational medtechs, with some major exceptions. But there will be more M&A reflected in next year's ranking based on 2018 revenues. Also, medtech groups leading the global market tightened their grip further in 2017, as providers chose to partner more and more with fewer suppliers who can offer a wider provision of services.

Commercial M & A

Blood-Collection Groups Must Test Blood For Chagas Disease Parasite, US FDA Says

Donated blood must be tested by blood-collection groups for evidence of infection with Trypanosoma cruzi, a parasite that causes Chagas disease – either for donation purposes or for use in manufacturing a medical device – FDA says in final guidance released Dec. 5.

Policy & Regulation In Vitro Diagnostics

Device/Diagnostics Quarterly Deal Statistics, Q3 2016

Q3 medtech financing doubled in dollar volume to $3 billion, with debt offerings again representing the majority of the aggregate; acquisitions totaled $5.3 billion, mainly due to Johnson & Johnson’s $4.3 billion buy of Abbott Medical Optics. Diagnostics financings, which brought in $85 million, continued to decline, but at $5 billion, acquisitions showed a slight increase over the previous quarter, with Danaher’s takeover of Cepheid accounting for most of the M&A volume.

Market Intelligence Deals

UK Diagnostic Fret Over Loss of Support In Evidence Centers Restructure

Changes are afoot for the four UK Diagnostic Evidence Co-operatives that help generate clinical and cost-effectiveness data for innovative IVDs. Companies worry it could mean diagnostic industry needs get lost among broad medtech targets. Also, a roundup of the British In Vitro Diagnostics Association's key priorities, including the EU IVD Regulation, procurement issues, antimicrobial resistance, and of course, Brexit, highlighted at the group's 2016 annual meeting.

United Kingdom In Vitro Diagnostics
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Therapeutic Drug Monitoring
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Ortho-Clinical Diagnostics Inc.
  • Senior Management
  • Martin D Madaus, PhD, Chmn. & CEO
    Jeffrey D Capello, CFO
    Alex Socarras, EVP, Commercial
    Robert Yates, COO
  • Contact Info
  • Ortho-Clinical Diagnostics Inc.
    Phone: (800) 828-6316
    100 Indigo Creek Dr.
    Rochester, NJ 14626
    USA
UsernamePublicRestriction

Register